Patents Represented by Attorney Henry P. Stevens

Find this attorney in the Justia Lawyer Directory

  • Method of treating transplanted tumors and cancerous cachexia with quinolinic dihydrazide
    Patent number: 4487775
    Abstract: Quinolinic dihydrazide will inhibit the growth of various transplanted tumors such as Walker 256 carcinoma in animals when administered orally or intraperitoneally.
    Type: Grant
    Filed: October 26, 1982
    Date of Patent: December 11, 1984
    Inventor: Joseph Gold
  • Anti Walker 256 carcinoma agent and combination thereof
    Patent number: 4328246
    Abstract: Clofibrate which lowers blood triglycerides has been found to be an affective anti Walker 256 carcinoma agent and when combined with hydrazine sulfate therapy the inhibition of growth of malignant Walker 256 carcinoma is outstanding.
    Type: Grant
    Filed: August 20, 1980
    Date of Patent: May 4, 1982
    Inventor: Joseph Gold
  • Method of treating tumors and cancerous cachexia with L-tryptophan
    Patent number: 4291048
    Abstract: A method of inhibiting the growth of tumors by inhibiting gluconeogenesis and thereby interrupting the process of cachexia by the internal administration of compositions containing L-tryptophan to mammals so afflicted is disclosed.
    Type: Grant
    Filed: May 31, 1979
    Date of Patent: September 22, 1981
    Inventor: Joseph Gold
  • Method of treating cancerous cachexia in humans with hydrazine sulfate
    Patent number: 4110437
    Abstract: Hydrazine sulfate alone or formulated with liquid or solid carriers will retard and reduce cancerous cachexia even in the absence of tumor reduction when administered to humans either orally or parenterally.
    Type: Grant
    Filed: February 3, 1977
    Date of Patent: August 29, 1978
    Inventor: Joseph Gold